Angiogenesis Inhibitors in NSCLC

Angiogenesis is a complex biological process that plays a relevant role in sustaining the microenvironment, growth, and metastatic potential of several tumors, including non-small cell lung cancer (NSCLC). Bevacizumab was the first angiogenesis inhibitor approved for the treatment of patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzo, Anna, Montanino, Agnese, Carillio, Guido, Costanzo, Raffaele, Sandomenico, Claudia, Normanno, Nicola, Piccirillo, Maria Carmela, Daniele, Gennaro, Perrone, Francesco, Rocco, Gaetano, Morabito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666703/
https://www.ncbi.nlm.nih.gov/pubmed/28934120
http://dx.doi.org/10.3390/ijms18102021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666703/
https://www.ncbi.nlm.nih.gov/pubmed/28934120
http://dx.doi.org/10.3390/ijms18102021

Ejemplares similares